IL-1β promotes angiogenesis by activating VEGF production during tumor progression (Carmi et al., 2013; Voronov et al., 2003), while IL-18 suppresses angiogenesis in cancer (Cao et al., 1999; Xing et al., 2016; Yang et al., 2010). The gene discussed is IL18; the disease is neoplasm.